Accuray (ARAY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 May, 2026Executive summary
Q3 FY2026 net revenue was $104.8 million, down 7% year-over-year, with a net loss of $11.8 million and gross margin declining to 24.1% from 27.9% due to lower product sales and higher logistics and parts costs.
Product revenue declined 13% to $49.7 million, while service revenue was $55.1 million, down 1% year-over-year; Americas revenue grew 20% but China revenue fell 23%.
Transformation plan delivered $10 million in margin improvements through Q3, ahead of the $12 million annual target, and included a 15% workforce reduction and $6.5 million in Q3 restructuring charges.
Strategic partnerships and innovation initiatives were expanded, and commercial leadership was enhanced with a new Chief Commercial Officer.
Fiscal 2026 guidance was withdrawn due to geopolitical uncertainty, especially in the Middle East, impacting shipments and service revenue.
Financial highlights
Gross profit for Q3 was $25.3 million (24.1% margin), down 20% year-over-year; adjusted EBITDA was $3.8 million, down from $6 million prior year.
Operating expenses for Q3 were $34.4 million, up 12% year-over-year, including $6.5 million in restructuring charges; excluding these, expenses fell 9%.
Net loss per share was $(0.09) for the quarter, compared to $(0.01) in the prior year.
Order backlog at quarter end was $356.2 million, down 21% from prior year; book-to-bill ratio was 1.0 for the quarter.
Cash, cash equivalents, and restricted cash at quarter end were $44.4 million; outstanding debt was $179.5 million, including $148.8 million term loan, $5 million revolver, and $18 million convertible notes.
Outlook and guidance
Fiscal 2026 revenue and adjusted EBITDA guidance were withdrawn due to significant unpredictability from geopolitical disruptions, especially in the Middle East and China.
Transformation plan is on track to exceed the $12 million target for FY2026, with at least $25 million in improvements expected by FY2027 and $10 million already achieved by Q3.
Management expects continued pressure on gross margins and net income due to inflation, supply chain challenges, and logistics costs through at least fiscal 2026.
The company believes it has sufficient liquidity for at least the next 12 months but is closely monitoring macroeconomic risks.
Restructuring costs are expected to decrease in future quarters, with most recognized by fiscal year-end.
Latest events from Accuray
- Shelf registration covers resale of 7M shares from warrants tied to recent financing.ARAY
Registration Filing17 Feb 2026 - Revenue and margin guidance cut as China headwinds, tariffs, and financing changes weigh.ARAY
Q2 202617 Feb 2026 - Record Q4 revenue and robust FY25 outlook highlight strong growth and global expansion.ARAY
Q4 20241 Feb 2026 - Growth driven by innovation, emerging markets, and margin expansion, with U.S. recovery expected.ARAY
Jefferies Global Healthcare Conference31 Jan 2026 - FY2025 guidance raised as China growth and service gains offset margin and revenue declines.ARAY
Q1 202516 Jan 2026 - Q3 FY25 revenue up 12%, net loss narrowed, but guidance cut on tariffs; EBITDA improved.ARAY
Q3 202527 Dec 2025 - Q2 revenue up 8% to $116.2M, net income $2.5M, margin 36.1%, guidance raised.ARAY
Q2 202524 Dec 2025 - Resale registration covers 23.4M shares from warrant exercises tied to recent financing.ARAY
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, equity plan increases, pay, and auditor ratification.ARAY
Proxy Filing1 Dec 2025